ReviewNature reviews. Clinical oncology2010
Making the best of PARP inhibitors in ovarian cancer.
Susana Banerjee et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
62 papers cite itlatest 60 shown
this paperpooled ittrialcites it
ReviewNature reviews. Clinical oncology2010
Susana Banerjee et al.PubMed ↗Publisher ↗
No numbers read from the abstract.